Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction

Purpose The aim of this study was to evaluate the effect of pneumatic vitreolysis (PVL) in the management of symptomatic focal vitreomacular traction (VMT). Patients and methods This prospective non-comparative interventional study was conducted on 21 eyes of 20 patients with isolated focal VMT det...

Full description

Bibliographic Details
Main Authors: Osama R Elnaggar, Islam S.H Ahmed, Amir R Gomaa, Amr M Elhady
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Delta Journal of Ophthalmology
Subjects:
Online Access:http://www.djo.eg.net/article.asp?issn=1110-9173;year=2023;volume=24;issue=4;spage=232;epage=239;aulast=Elnaggar
_version_ 1797352162857058304
author Osama R Elnaggar
Islam S.H Ahmed
Amir R Gomaa
Amr M Elhady
author_facet Osama R Elnaggar
Islam S.H Ahmed
Amir R Gomaa
Amr M Elhady
author_sort Osama R Elnaggar
collection DOAJ
description Purpose The aim of this study was to evaluate the effect of pneumatic vitreolysis (PVL) in the management of symptomatic focal vitreomacular traction (VMT). Patients and methods This prospective non-comparative interventional study was conducted on 21 eyes of 20 patients with isolated focal VMT detected by optical coherence tomography (OCT). All patients were symptomatic complaining of decreased vision and/or metamorphopsia with persistence of VMT for at least 3 months before intervention. All patients received a single intravitreal injection of 0.3 ml pure perfluoropropane (C3F8) and were followed up for 6 months post-injection. During the follow up period, the patients were evaluated regarding the occurrence of release of VMT as detected by OCT, the change in best corrected visual acuity (BCVA), and the change in central macular thickness (CMT) by OCT. Results The single intravitreal gas injection of C3F8 resulted in the release of VMT in 16 (76.2%) eyes. The mean BCVA significantly improved from 0.71±0.16 LogMAR (range: 1–0.5) at baseline to 0.38±0.22 LogMAR (range: 1.0–0.2) by the final visit at 6 months postoperatively (P<0.001). In addition, the mean CMT significantly decreased from 461.67±68.60 µm (range: 318–573 µm) at baseline to 331.55±90.27 µm (range: 278–568 µm) at 6 months postoperatively (P<0.001). One patient developed a retinal break and was treated by retinopexy, and one patient developed a full-thickness macular hole that was treated by vitrectomy. Conclusions PVL was found to be an effective method for treatment of symptomatic VMT.
first_indexed 2024-03-08T13:12:14Z
format Article
id doaj.art-61c4b519bcfb44c29bf3da2c081650bd
institution Directory Open Access Journal
issn 1110-9173
2090-4835
language English
last_indexed 2024-03-08T13:12:14Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Delta Journal of Ophthalmology
spelling doaj.art-61c4b519bcfb44c29bf3da2c081650bd2024-01-18T11:12:34ZengWolters Kluwer Medknow PublicationsDelta Journal of Ophthalmology1110-91732090-48352023-01-0124423223910.4103/djo.djo_31_23Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular tractionOsama R ElnaggarIslam S.H AhmedAmir R GomaaAmr M ElhadyPurpose The aim of this study was to evaluate the effect of pneumatic vitreolysis (PVL) in the management of symptomatic focal vitreomacular traction (VMT). Patients and methods This prospective non-comparative interventional study was conducted on 21 eyes of 20 patients with isolated focal VMT detected by optical coherence tomography (OCT). All patients were symptomatic complaining of decreased vision and/or metamorphopsia with persistence of VMT for at least 3 months before intervention. All patients received a single intravitreal injection of 0.3 ml pure perfluoropropane (C3F8) and were followed up for 6 months post-injection. During the follow up period, the patients were evaluated regarding the occurrence of release of VMT as detected by OCT, the change in best corrected visual acuity (BCVA), and the change in central macular thickness (CMT) by OCT. Results The single intravitreal gas injection of C3F8 resulted in the release of VMT in 16 (76.2%) eyes. The mean BCVA significantly improved from 0.71±0.16 LogMAR (range: 1–0.5) at baseline to 0.38±0.22 LogMAR (range: 1.0–0.2) by the final visit at 6 months postoperatively (P<0.001). In addition, the mean CMT significantly decreased from 461.67±68.60 µm (range: 318–573 µm) at baseline to 331.55±90.27 µm (range: 278–568 µm) at 6 months postoperatively (P<0.001). One patient developed a retinal break and was treated by retinopexy, and one patient developed a full-thickness macular hole that was treated by vitrectomy. Conclusions PVL was found to be an effective method for treatment of symptomatic VMT.http://www.djo.eg.net/article.asp?issn=1110-9173;year=2023;volume=24;issue=4;spage=232;epage=239;aulast=Elnaggarbest corrected visual acuityperfluoropropane (c3f8)central macular thicknessintravitreal gas injectionoptical coherence tomographypneumatic vitreolysisvitreomacular traction
spellingShingle Osama R Elnaggar
Islam S.H Ahmed
Amir R Gomaa
Amr M Elhady
Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
Delta Journal of Ophthalmology
best corrected visual acuity
perfluoropropane (c3f8)
central macular thickness
intravitreal gas injection
optical coherence tomography
pneumatic vitreolysis
vitreomacular traction
title Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
title_full Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
title_fullStr Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
title_full_unstemmed Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
title_short Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
title_sort evaluating the effect of perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
topic best corrected visual acuity
perfluoropropane (c3f8)
central macular thickness
intravitreal gas injection
optical coherence tomography
pneumatic vitreolysis
vitreomacular traction
url http://www.djo.eg.net/article.asp?issn=1110-9173;year=2023;volume=24;issue=4;spage=232;epage=239;aulast=Elnaggar
work_keys_str_mv AT osamarelnaggar evaluatingtheeffectofperfluoropropaneassistedpneumaticvitreolysisincasesofsymptomaticfocalvitreomaculartraction
AT islamshahmed evaluatingtheeffectofperfluoropropaneassistedpneumaticvitreolysisincasesofsymptomaticfocalvitreomaculartraction
AT amirrgomaa evaluatingtheeffectofperfluoropropaneassistedpneumaticvitreolysisincasesofsymptomaticfocalvitreomaculartraction
AT amrmelhady evaluatingtheeffectofperfluoropropaneassistedpneumaticvitreolysisincasesofsymptomaticfocalvitreomaculartraction